tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Compare Everest Medicines Ltd. (1952) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$51.50
HK$13.78B
-17.77
-3.33%
InnoCare Pharma Ltd.
HK$11.72
HK$17.52B
-83.00
111.97%
4 Buy
1 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Keymed Biosciences, Inc.
HK$62.80
HK$15.62B
-54.40
88.64%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$8.96B
-15.59
53.77%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.93B
14.32
4.52%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
38.96
-2.19
-5.32%
HK:9969
InnoCare Pharma Ltd.
11.72
6.15
110.41%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2162
Keymed Biosciences, Inc.
55.65
26.50
90.91%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.50
5.30
51.96%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
25.92
2.75
11.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts